glp-1 receptor agonists brands list top glp 1 drug companies Analogues Transform Metabolic Disease Management 2025’s Breakthrough GLP-1 Obesity Treatments:
Description
Introduction Recent data from the International Diabetes Foundation (IDF) Diabetes World Atlas released at the end of 2021 shows a consistently rising prevalence of type 2 diabetes (T2D) with different incidence increases in various regions of the world

ROR = 1.1, 95% CI 1.091.11) Gastrointestinal disorders (n = 33,685
Monami, M., Dicembrini, I

Survey of Ophthalmology, 68 (6), 10711083

Diabetes Spectrum
